Adjuvant cemiplimab became a category 1 preferred option after surgery and adjuvant RT for extremely high-risk nodal or nonnodal CSCC, supported by C-POST disease-free survival benefit. Extremely high ...
Immunotherapies are transforming treatment and improving outcomes for patients with advanced cSCC, according to Todd Schlesinger, MD. In part 1 of the interview, he described how cSCC compares with ...
The best way to detect skin cancer is to know what skin cancer looks like, do monthly self-exams and have regular exams by your health care provider to check for abnormalities that could be cancerous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results